MARKET

SER

SER

Serina Therapeutics
AMEX
1.900
-0.020
-1.04%
After Hours: 1.890 -0.01 -0.53% 19:48 07/02 EDT
OPEN
1.910
PREV CLOSE
1.920
HIGH
1.970
LOW
1.900
VOLUME
19.12K
TURNOVER
--
52 WEEK HIGH
7.92
52 WEEK LOW
1.220
MARKET CAP
28.50M
P/E (TTM)
-0.9613
1D
5D
1M
3M
1Y
5Y
1D
Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goal
NASDAQ · 21h ago
Serina Therapeutics Price Target Announced at $8.00/Share by BTIG
Dow Jones · 1d ago
Serina Therapeutics Initiated at Buy by BTIG
Dow Jones · 1d ago
BTIG Initiates Coverage On Serina Therapeutics with Buy Rating, Announces Price Target of $8
Benzinga · 1d ago
Serina Therapeutics initiated with a Buy at BTIG
TipRanks · 2d ago
Gannet BioChem Partners With Serina To Support SER-252 Development For Parkinson's Disease
NASDAQ · 2d ago
Gannet BioChem To Support Development Activities For SER-252, Serina Therapeutics' Investigational Therapy For Advanced Parkinson's Disease
Benzinga · 2d ago
Weekly Report: what happened at SER last week (0622-0626)?
Weekly Report · 4d ago
More
About SER
Serina Therapeutics Inc. is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. The Company's POZ Platform provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Its proprietary POZ technology is based on a synthetic, water soluble, low viscosity polymer called poly(2-oxazoline). Its POZ technology is engineered to provide greater control in drug loading and more precision in the rate of release of attached drugs delivered via subcutaneous injection. SER-252 is the Company’s lead candidate for advanced Parkinson’s disease. SER-252 is an investigational apomorphine therapy developed with its POZ platform and designed to provide continuous dopaminergic stimulation.

Webull offers Serina Therapeutics Inc stock information, including AMEX: SER real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SER stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SER stock methods without spending real money on the virtual paper trading platform.